logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jonathan W. Goldman

james cancer hospital & solove research institute

67H指数
793论文数
3.4W被引数
收录论文 117
发表时间
logo
Small Cell Lung Cancer, Version 2.2026 Featured Updates to the NCCN Guidelines小细胞肺癌，2026年第2版NCCN指南特色更新
errJournal of the National Comprehensive Cancer Network
IF16.4
err2026-01-01
err0
PREAI
errGanti, Apar Kishor P.; Loo, Billy W.; Badiyan, Shahed; Bassetti, Michael; Bestvina, Christine; Chiang, Anne; Choudhury, Noura; D'Avella, Christopher A.; Daly, Megan; Dowlati, Afshin; Edelman, Martin; Florsheim, Charles; Gold, Kathryn A.; Goldman, Jonathan W.; Grecula, John C.; Hann, Christine; Khalil, Maya; Lee, Robert; Malhotra, Jyoti; Merritt, Robert E.; Mohindra, Nisha; Molina, Julian R.; Moran, Cesar; Mulvey, Claire; Osmundson, Evan C.; Patel, Shiven; Patil, Tejas; Pokharel, Saraswati; Puri, Sonam; Qin, Angel; Sands, Jacob; Shields, Misty; Tailor, Tina D.; Waqar, Saiama N.; Cassara, Carly J.; Ramakrishnan, Swathi
err分享
err收藏
Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer立体定向体部放射治疗在Ⅰ期非小细胞肺癌中的应用趋势
errCHEST
IF8.6
err2025-11-12
err0
PREAI
errSara Sakowitz; Haley I. Tupper; Lawrence N. Benjamin; Scott Oh; Tao He; Reza Ronaghi; Colleen L. Channick; Brian J. Rosenberg; Ramin Salehi-rad; Malcolm I. Smith; Joanne M. Bando; Timothy J. Young; Igor Barjaktarvic; Maria A. Velez Velez; Arjan Gower; Amy L. Cummings; Jonathan Goldman; Aaron E. Lisberg; Edward B. Garon; Jane Yanagawa
err分享
err收藏
Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report奥希替尼联合萨沃利替尼治疗在一线奥希替尼治疗后具有MET改变的EGFR突变晚期NSCLC患者：临床结局、安全性和生物标志物分析：简要报告
errJournal of Thoracic Oncology
IF20.8
err2025-10-21
err0
PREAI
errXiuning Le; Christina Baik; Byoung Chul Cho; Jonathan W. Riess; Zofia Piotrowska; Adrianus Johannes de Langen; Sarah B. Goldberg; Jonathan W. Goldman; Noemi Reguart; Yoshimasa Shiraishi; Helen Ambrose; Paula G. Fraenkel; Brayan Merchan Ruiz; Paul E. Smith; Kwan Ho Tang; Helena A. Yu
err分享
err收藏
Durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: outcomes in age, sex, and platinum subgroups from the phase 3 CASPIAN study度伐利尤单抗联合铂类-依托泊苷治疗广泛期小细胞肺癌：CASPIAN III期研究中不同年龄、性别和铂类亚组的结果
errClinical Lung Cancer
IF3.3
err2025-08-05
err0
errOAAI
errNiels Reinmuth; Jonathan W. Goldman; Yuanbin Chen; Katsuyuki Hotta; Dmytro Trukhin; Galina Statsenko; Maximilian Hochmair; Mustafa Özgüroğlu; Jun Ho Ji; Marina Chiara Garassino; Artem Poltoratskiy; Francesco Verderame; Libor Havel; Igor Bondarenko; György Losonczy; Nikolay Conev; Shannon Kummer; Helen Mann; Priti Chugh; Tapashi Dalvi; Luis Paz-Ares
err分享
err收藏
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC—A Brief Report更新了来自II期PHAROS研究的encorafenib联合binimetinib在BRAF V600E突变型转移性NSCLC患者中的疗效和安全性——简报
errJournal of Thoracic Oncology
IF20.8
err2025-06-04
err0
errOAAI
errGregory J. Riely; Myung-Ju Ahn; Jeffrey M. Clarke; Ibiayi Dagogo-Jack; Raymond Esper; Enriqueta Felip; Francesco Gelsomino; Jonathan W. Goldman; Maen Hussein; Melissa Johnson; Kristen A. Marrone; Daniel Morgensztern; Ernest Nadal; Marcelo V. Negrao; Michael Offin; Mariano Provencio; Suresh S. Ramalingam; Logan Roof; Rachel E. Sanborn; Egbert F. Smit; Anne Tsao; Tiziana Usari; Ann Alcasid; Keith Wilner; Svitlana Tonkovyd; Xiaosong Zhang; Bruce E. Johnson
err分享
err收藏
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS StudyAmivantamab在晚期NSCLC和MET外显子14跳跃突变参与者中的应用: CHRYSALIS研究的最终结果
errJournal of Thoracic Oncology
IF20.8
err2025-05-16
err0
PREAI
errMatthew G. Krebs; Byoung Chul Cho; Sandrine Hiret; Ji-Youn Han; Ki Hyeong Lee; Casilda Llácer Pérez; Filippo De Braud; Eric B. Haura; Rachel E. Sanborn; James Chih-Hsin Yang; Catherine A. Shu; Koichi Goto; Makoto Nishio; Jun Zhao; Zhijie Wang; Pascale Tomasini; Enriqueta Felip; Jonathan W. Goldman; Sai-Hong Ignatius Ou; Michael Boyer; Grace Gao; Siyang Qu; Joshua C. Curtin; Xuesong Lyu; Robert W. Schnepp; Priya Kim; Meena Thayu; Roland E. Knoblauch; Patricia Lorenzini; Mahadi Baig; Alexander I. Spira; Natasha B. Leighl
err分享
err收藏
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study在CASPIAN III期研究中，广泛期小细胞肺癌患者自报的不良事件
errFUTURE ONCOLOGY
IF2.6
err2025-05-07
err0
errOAAI
errOzguroglu, Mustafa; Goldman, Jonathan W.; Chen, Yuanbin; Garassino, Marina Chiara; Medic, Nenad; Mann, Helen; Chugh, Priti; Dalvi, Tapashi; Paz-Ares, Luis
err分享
err收藏
Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking Patients简报：无吸烟史小细胞肺癌的基因组景观
errClinical Lung Cancer
IF3.3
err2025-03-31
err0
errOAAI
errMichael S. Oh; Edward B. Garon; Aaron E. Lisberg; Amy L. Cummings; Alex Barrett; Arya Ashok; Elizabeth Mauer; Binyam Yilma; Jonathan W. Goldman
err分享
err收藏
Water Disinfection Systems for Pools and Spas: Advantages, Disadvantages, and Consumer Views in the US
errACS ES&T WATER
IF4.3
err2025-01-09
err0
errOAAI
errJarin, Mourin; Ly, Jackie; Goldman, Jonathan; Xie, Xing
err分享
err收藏
Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinibtelisotuzumab vedotin联合奥希替尼治疗c-met蛋白过度表达、EGFR突变的局部晚期/转移性非小细胞肺癌 (NSCLC) 患者的Ib期研究结果
errANNALS OF ONCOLOGY
IF65.4
err2025-01-01
err2
PREAI
errHorinouchi, H.; Cho, B. C.; Camidge, D. R.; Goto, K.; Tomasini, P.; Li, Y.; Vasilopoulos, A.; Brunsdon, P.; Hoffman, D.; Shi, W.; Bolotin, E.; Blot, V.; Goldman, J.
err分享
err收藏
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
errMOLECULAR CANCER
IF33.9
err2024-05-30
err4
errOAAI
errXie, Mingchao; Vuko, Miljenka; Rodriguez-Canales, Jaime; Zimmermann, Johannes; Schick, Markus; O'Brien, Cathy; Paz-Ares, Luis; Goldman, Jonathan W.; Garassino, Marina Chiara; Gay, Carl M.; Heymach, John V.; Jiang, Haiyi; Barrett, J. Carl; Stewart, Ross A.; Lai, Zhongwu; Byers, Lauren A.; Rudin, Charles M.; Shrestha, Yashaswi
err分享
err收藏
Phase I trial of intratumoral administration of autologous CCL21 gene-modified dendritic cells in combination with pembrolizumab for advanced NSCLC: Feasibility of repeated IT injections
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errLiu, Bin; Lisberg, Aaron; Salehi-Rad, Ramin; Oh, Michael; Lee, Jay M.; Tran, Linh M.; Krysan, Kostyantyn; Lim, Raymond J.; Dumitras, Camelia; Jing, Zhe; Abtin, Fereidoun; Suh, Robert D.; Genshaft, Scott J.; Oh, Scott S.; Fishbein, Gregory A.; Kaul, Anita; Kahlon, Kanwarpal S.; Ashouri, Shahryar A.; Goldman, Jonathan W.; Elashoff, David A.; Garon, Edward; Dubinett, Steven M.
err分享
err收藏
Amivantamab in wild-type advanced non-small cell lung cancer after disease progression on checkpoint inhibition and chemotherapy: Results from the phase 1b CHRYSALIS study
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errCho, Byoung Chul; Goldman, Jonathan; Leighl, Natasha; De Braud, Filippo; Lee, Ki Hyeong; Ghiringhelli, Francois; Garrido, Pilar; Peguero, Julio; Besse, Benjamin; Cassier, Philippe; Girard, Nicolas; de Miguel, Maria; Alvarez, Rosa; Greystroke, Alastair; Ohe, Yuichiro; Hsia, Te-Chun; Curtin, Joshua C.; Chowdhury, Sanjib; Lyu, Xuesong; Gao, Grace; Qu, Siyang; Lorenzini, Patricia; Kapoor, Aastha; Kim, Priya; Baig, Mahadi; Thayu, Meena; Knoblauch, Roland E.; Hiret, Sandrine; Tomasini, Pascale
err分享
err收藏
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results共享新抗原疫苗联合免疫检查点阻断治疗晚期转移性实体瘤: 1期临床试验中期结果
errNATURE MEDICINE
IF50
err2024-03-27
err16
PREAI
errRappaport, Amy R.; Kyi, Chrisann; Lane, Monica; Hart, Meghan G.; Johnson, Melissa L.; Henick, Brian S.; Liao, Chih-Yi; Mahipal, Amit; Shergill, Ardaman; Spira, Alexander I.; Goldman, Jonathan W.; Scallan, Ciaran D.; Schenk, Desiree; Palmer, Christine D.; Davis, Matthew J.; Kounlavouth, Sonia; Kemp, Lindsey; Yang, Aaron; Li, Yaojun John; Likes, Molly; Shen, Annie; Boucher, Gregory R.; Egorova, Milana; Veres, Robert L.; Espinosa, J. Aaron; Jaroslavsky, Jason R.; Tardif, Lauren D. Kraemer; Acrebuche, Lindsey; Puccia, Christopher; Sousa, Leiliane; Zhou, Rita; Bae, Kyounghwa; Hecht, J. Randolph; Carbone, David P.; Johnson, Benny; Allen, Andrew; Ferguson, Andrew R.; Jooss, Karin
err分享
err收藏
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC研究总结: 奥希替尼治疗EGFR突变非小细胞肺癌的总生存期
errTARGETED ONCOLOGY
IF4
err2024-03-11
err0
errOAAI
errTsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Bonanno, Laura; Domine, Manuel; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long
err分享
err收藏
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
errFUTURE ONCOLOGY
IF2.6
err2024-02-15
err0
errOAAI
errRiely, Gregory J.; Smit, Egbert F.; Ahn, Myung-Ju; Felip, Enriqueta; Ramalingam, Suresh S.; Tsao, Anne; Johnson, Melissa; Gelsomino, Francesco; Esper, Raymond; Nadal, Ernest; Offin, Michael; Provencio, Mariano; Clarke, Jeffrey; Hussein, Maen; Otterson, Gregory A.; Dagogo-Jack, Ibiayi; Goldman, Jonathan W.; Morgensztern, Daniel; Alcasid, Ann; Usari, Tiziana; Wissel, Paul; Wilner, Keith; Pathan, Nuzhat; Tonkovyd, Svitlana; Johnson, Bruce E.
err分享
err收藏
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2023-11-30
err91
PREAI
errZhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Liu, Baogang; Paz-Ares, Luis; Cheng, Susanna; Kitazono, Satoru; Thiagarajan, Muthukkumaran; Goldman, Jonathan W.; Sabari, Joshua K.; Sanborn, Rachel E.; Mansfield, Aaron S.; Hung, Jen-Yu; Boyer, Michael; Popat, Sanjay; Mourao Dias, Josiane; Felip, Enriqueta; Majem, Margarita; Gumus, Mahmut; Kim, Sang-we; Ono, Akira; Xie, John; Bhattacharya, Archan; Agrawal, Trishala; Shreeve, S. Martin; Knoblauch, Roland E.; Park, Keunchil; Girard, Nicolas; PAPILLON Investigators
err分享
err收藏
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC奥希替尼联合或不联合化疗治疗EGFR突变的晚期NSCLC
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2023-11-23
err140
PREAI
errPlanchard, D.; Janne, P. A.; Cheng, Y.; Yang, J. C. -H.; Yanagitani, N.; Kim, S-W; Sugawara, S.; Yu, Y.; Fan, Y.; Geater, S. L.; Laktionov, K.; Lee, C. K.; Valdiviezo, N.; Ahmed, S.; Maurel, J-M; Andrasina, I; Goldman, J.; Ghiorghiu, D.; Rukazenkov, Y.; Todd, A.; Kobayashi, K.
err分享
err收藏
Phase 1b efficacy of telisotuzumab vedotin and osimertinib in Asian vs non-Asian patients with advanced NSCLC
errANNALS OF ONCOLOGY
IF65.4
err2023-11-01
err0
errOAAI
errHorinouchi, Hidehito; Goldman, Jonathan; Cho, Byoung Chul; Tomasini, Pascale; Dunbar, Martin; Hoffman, David; Parikh, Apurvasena; Blot, Vincent; Camidge, D. Ross
err分享
err收藏
Telisotuzumab vedotin monotherapy in Asian patients with c-Meteoverexpressing advanced non-small cell lung cancer
errANNALS OF ONCOLOGY
IF65.4
err2023-11-01
err0
errOAAI
errHorinouchi, Hidehito; Camidge, D. Ross; Bar, Jair; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan; Bradbury, Penelope; Daaboul, Nathalie; Tomasini, Pascale; Ciuleanu, Tudor; Planchard, David; Moskovitz, Mor; Girard, Nicolas; Dunbar, Martin; Bolotin, Ellen; Looman, Jim; Ratajczak, Christine; Lu, Shun
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
John C. Morris
H 指数: 212 · 论文数: 2.4K
J
John D. Minna
H 指数: 174 · 论文数: 2.3K
K
Keith T. Flaherty
H 指数: 146 · 论文数: 1.7K
R
Richard L. Huganir
H 指数: 145 · 论文数: 490
P
Patrick Y. Wen
H 指数: 145 · 论文数: 1.9K
查看更多